$MYSZ

My Size, Inc. (MYSZ): Entry into a Material Definitive Agreement

My Size, Inc. (MYSZ) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 MySize Announces $2.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules AIRPORT CITY, Israel, Sept. 15, 2026 -- MySize, Inc. (NASDAQ: MYSZ) (“MySize” or the “Company”), a global provider of AI-driven retail technology solutions, today announced that i

Original reporting
Published Sep 16, 2026, 1:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 1:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$MYSZ
Bearish
medium confidence
Mentioned
$MYSZ
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MYSZBearishMed
01

Why it matters

The $2.5 M at‑the‑market private placement adds cash for working capital and possible strategic moves, with limited immediate price impact due to small size.

02

Market read

A micro‑cap financing disclosure with modest immediate relevance; may interest niche investors tracking AI retail tech.

03

What to watch

Potential strategic use of proceeds for defense‑tech acquisitions may create future upside.

Relevance 6/10Novelty 8/10Timing: on September 16, 2026 (same‑day filing)

Background

My Size, Inc. (NASDAQ:MYSZ) develops AI‑enabled sizing solutions for fashion and retail, and is exploring defense‑technology acquisitions.

Company-level read

Ticker impact

$MYSZBearishMedium confidence
Context

My Size, Inc. filed an 8‑K announcing a $2.5 million private placement of common stock and warrants priced at $1.91 per share.

Expected impact

Minor downward pressure due to dilution, offset by cash infusion for working capital.

Evidence & confidence

Small raise size relative to market cap suggests limited market move; investors may view as routine financing.

Market effects

Provides a modest funding signal for AI‑driven retail tech sector, but unlikely to shift sector sentiment.

No significant regional effect; limited to investors in the micro‑cap space.

Low global relevance; primarily a micro‑cap financing event.

Counterpoint

The dilution from new shares could outweigh the benefit of cash, potentially pressuring the stock.

Key entities

  • H.C. Wainwright & Co.

    Exclusive placement agent for the private offering.

Related articles

$MYSZMedAI 8/10

My Size Inc.: MySize Reports 53% Year-Over-Year Revenue Growth in Second Quarter 2026 as Integrated Fashion Platform Continues to Scale

MySize, Inc. (NASDAQ: MYSZ) reported Q2 2026 revenue of $3.07 million, up 53% year over year, and $5.46 million for the first half, up 57%. Percentil revenue rose to $413,000. Gross margin fell to about 31.7% as commerce mix increased. Net loss was $1.75 million. Cash used in operations was $1.97 million for six months.

$MYSZMed

My Size, Inc. (MYSZ): Results of Operations and Financial Condition

My Size, Inc. (MYSZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MySize Reports 53% Year-Over-Year Revenue Growth in Second Quarter 2026 as Integrated Fashion Platform Continues to Scale Quarterly revenue reaches $3.1 million; first-half revenue increases 57% to $5.5 million Company enters next phase focused on contribution margin

$KAIMed

Kadant (KAI), What Is Behind The Fresh Attention?

Kadant (KAI) announced leadership succession plans and a quarterly dividend of $0.36 per share. Its stock has fallen 15% in the past month to $265.56, with a 1-year return of -13%, though 3- and 5-year returns remain positive. Analysts debate its valuation, with some suggesting it's undervalued at $335 per share, while others note its high P/E ratio of 28.6x compared to peers.